| P2093 | author name string | Tom Schaberg | |
| | Annicka Reuss | |
| | Mathias Pletz | |
| | Regine Lehnert | |
| P2860 | cites work | The value of neuraminidase inhibitors for the prevention and treatment of seasonal influenza: a systematic review of systematic reviews | Q21090775 |
| | Amantadine and rimantadine for influenza A in children and the elderly | Q24187883 |
| | Neuraminidase inhibitors for preventing and treating influenza in adults and children | Q24197463 |
| | Neuraminidase inhibitors for preventing and treating influenza in children (published trials only) | Q24200222 |
| | Neuraminidase inhibitors for the treatment of influenza infection in people with cystic fibrosis | Q24200454 |
| | Neuraminidase inhibitors for preventing and treating influenza in healthy adults and children | Q24203905 |
| | Neuraminidase inhibitors for preventing and treating influenza in healthy adults | Q24240097 |
| | Amantadine and rimantadine for influenza A in adults | Q24246351 |
| | Effectiveness of neuraminidase inhibitors in reducing mortality in patients admitted to hospital with influenza A H1N1pdm09 virus infection: a meta-analysis of individual participant data. | Q30362392 |
| | Systematic review: safety and efficacy of extended-duration antiviral chemoprophylaxis against pandemic and seasonal influenza. | Q30379481 |
| | Impact of neuraminidase inhibitors on influenza A(H1N1)pdm09-related pneumonia: an individual participant data meta-analysis. | Q30381799 |
| | Clinical aspects of pandemic 2009 influenza A (H1N1) virus infection | Q30388857 |
| | Effectiveness of antiviral treatment in human influenza A(H5N1) infections: analysis of a Global Patient Registry. | Q30393490 |
| | Impact of neuraminidase inhibitor treatment on outcomes of public health importance during the 2009-2010 influenza A(H1N1) pandemic: a systematic review and meta-analysis in hospitalized patients | Q30424329 |
| | Oseltamivir: the real world data | Q30817384 |
| | Oseltamivir, zanamivir and amantadine in the prevention of influenza: A systematic review | Q34143963 |
| | Oseltamivir and risk of lower respiratory tract complications in patients with flu symptoms: a meta-analysis of eleven randomized clinical trials | Q34192909 |
| | Oseltamivir treatment for influenza in adults: a meta-analysis of randomised controlled trials | Q34460803 |
| | Oseltamivir and inhaled zanamivir as influenza prophylaxis in Thai health workers: a randomized, double-blind, placebo-controlled safety trial over 16 weeks | Q36593645 |
| | Oseltamivir-resistant influenza virus A (H1N1), Europe, 2007-08 season | Q37164761 |
| | Amantadine, oseltamivir and zanamivir for the prophylaxis of influenza (including a review of existing guidance no. 67): a systematic review and economic evaluation | Q37392434 |
| | Antiviral drugs for the treatment of influenza: a systematic review and economic evaluation. | Q37642921 |
| | Zanamivir prophylaxis: an effective strategy for the prevention of influenza types A and B within households | Q39400858 |
| | Efficacy of oseltamivir treatment started within 5 days of symptom onset to reduce influenza illness duration and virus shedding in an urban setting in Bangladesh: a randomised placebo-controlled trial | Q40152886 |
| | Early administration of oral oseltamivir increases the benefits of influenza treatment | Q40568853 |
| | Management of Adult Community-acquired Pneumonia and Prevention - Update 2016 | Q40773520 |
| | Efficacy and safety of oseltamivir in treatment of acute influenza: a randomised controlled trial. Neuraminidase Inhibitor Flu Treatment Investigator Group. | Q48719424 |
| | Efficacy and safety of oral oseltamivir for influenza prophylaxis in transplant recipients | Q84447040 |
| P433 | issue | 47 | |
| P921 | main subject | pandemic | Q12184 |
| P304 | page(s) | 799-807 | |
| P577 | publication date | 2016-11-01 | |
| P1433 | published in | Deutsches Ärzteblatt international | Q27722165 |
| P1476 | title | Antiviral Medications in Seasonal and Pandemic Influenza | |
| P478 | volume | 113 | |